Literature DB >> 35279150

Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Ranjith Kumar Kankala1,2,3, Ya-Hui Han4,5, Hong-Ying Xia4,5, Shi-Bin Wang4,5,6, Ai-Zheng Chen4,5,6.   

Abstract

Despite exceptional morphological and physicochemical attributes, mesoporous silica nanoparticles (MSNs) are often employed as carriers or vectors. Moreover, these conventional MSNs often suffer from various limitations in biomedicine, such as reduced drug encapsulation efficacy, deprived compatibility, and poor degradability, resulting in poor therapeutic outcomes. To address these limitations, several modifications have been corroborated to fabricating hierarchically-engineered MSNs in terms of tuning the pore sizes, modifying the surfaces, and engineering of siliceous networks. Interestingly, the further advancements of engineered MSNs lead to the generation of highly complex and nature-mimicking structures, such as Janus-type, multi-podal, and flower-like architectures, as well as streamlined tadpole-like nanomotors. In this review, we present explicit discussions relevant to these advanced hierarchical architectures in different fields of biomedicine, including drug delivery, bioimaging, tissue engineering, and miscellaneous applications, such as photoluminescence, artificial enzymes, peptide enrichment, DNA detection, and biosensing, among others. Initially, we give a brief overview of diverse, innovative stimuli-responsive (pH, light, ultrasound, and thermos)- and targeted drug delivery strategies, along with discussions on recent advancements in cancer immune therapy and applicability of advanced MSNs in other ailments related to cardiac, vascular, and nervous systems, as well as diabetes. Then, we provide initiatives taken so far in clinical translation of various silica-based materials and their scope towards clinical translation. Finally, we summarize the review with interesting perspectives on lessons learned in exploring the biomedical applications of advanced MSNs and further requirements to be explored.
© 2022. The Author(s).

Entities:  

Keywords:  Biocompatibility; Degradability; Drug delivery; Immune therapy; Metal-impregnation; Surface immobilization; Tissue engineering

Mesh:

Substances:

Year:  2022        PMID: 35279150      PMCID: PMC8917689          DOI: 10.1186/s12951-022-01315-x

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   10.435


  398 in total

1.  A glucose-responsive controlled release of insulin system based on enzyme multilayers-coated mesoporous silica particles.

Authors:  Wenru Zhao; Hongti Zhang; Qianjun He; Yongsheng Li; Jinlou Gu; Liang Li; Hua Li; Jianlin Shi
Journal:  Chem Commun (Camb)       Date:  2011-07-22       Impact factor: 6.222

2.  Nanoceria-triggered synergetic drug release based on CeO(2) -capped mesoporous silica host-guest interactions and switchable enzymatic activity and cellular effects of CeO(2).

Authors:  Can Xu; Youhui Lin; Jiasi Wang; Li Wu; Weili Wei; Jinsong Ren; Xiaogang Qu
Journal:  Adv Healthc Mater       Date:  2013-04-30       Impact factor: 9.933

3.  Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma.

Authors:  Zheng Wang; Dan Shao; Zhimin Chang; Mengmeng Lu; Yingshuai Wang; Juan Yue; Dian Yang; Mingqiang Li; Qiaobing Xu; Wen-Fei Dong
Journal:  ACS Nano       Date:  2017-11-17       Impact factor: 15.881

4.  A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose.

Authors:  Chi-An Cheng; Wei Chen; Le Zhang; Holden H Wu; Jeffrey I Zink
Journal:  J Am Chem Soc       Date:  2019-10-25       Impact factor: 15.419

5.  MyoD Overexpressed Equine Adipose-Derived Stem Cells Enhanced Myogenic Differentiation Potential.

Authors:  Soo-Eun Sung; Meeyul Hwang; Ah-Young Kim; Eun-Mi Lee; Eun-Joo Lee; Su-Kyeong Hwang; Shin-Yoon Kim; Hong-Kyun Kim; Kyu-Shik Jeong
Journal:  Cell Transplant       Date:  2016-11       Impact factor: 4.064

6.  Micelles of poly(styrene-b-2-vinylpyridine-b-ethylene oxide) with blended polystyrene core and their application to the synthesis of hollow silica nanospheres.

Authors:  Dian Liu; Manickam Sasidharan; Kenichi Nakashima
Journal:  J Colloid Interface Sci       Date:  2011-03-08       Impact factor: 8.128

7.  Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.

Authors:  Piaoping Yang; Zewei Quan; Lanlan Lu; Shanshan Huang; Jun Lin
Journal:  Biomaterials       Date:  2007-11-08       Impact factor: 12.479

8.  Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma.

Authors:  Zheng Wang; Ying-Shuai Wang; Zhi-Min Chang; Li Li; Yi Zhang; Meng-Meng Lu; Xiao Zheng; Mingqiang Li; Dan Shao; Jing Li; Li Chen; Wen-Fei Dong
Journal:  Chem Biol Drug Des       Date:  2016-10-26       Impact factor: 2.817

9.  Ru nanoparticles dispersed on magnetic yolk-shell nanoarchitectures with Fe3O4 core and sulfoacid-containing periodic mesoporous organosilica shell as bifunctional catalysts for direct conversion of cellulose to isosorbide.

Authors:  Ying Yang; Wen Zhang; Feng Yang; Biao Zhou; Dehong Zeng; Na Zhang; Guoming Zhao; Shijie Hao; Xin Zhang
Journal:  Nanoscale       Date:  2018-02-01       Impact factor: 7.790

10.  A novel visible light responsive nanosystem for cancer treatment.

Authors:  M Martínez-Carmona; D Lozano; A Baeza; M Colilla; M Vallet-Regí
Journal:  Nanoscale       Date:  2017-10-26       Impact factor: 7.790

View more
  8 in total

1.  An injectable photo-cross-linking silk hydrogel system augments diabetic wound healing in orthopaedic surgery through spatiotemporal immunomodulation.

Authors:  Jiawei Mei; Jun Zhou; Lingtong Kong; Yong Dai; Xianzuo Zhang; Wenqi Song; Chen Zhu
Journal:  J Nanobiotechnology       Date:  2022-05-14       Impact factor: 9.429

Review 2.  Inorganic Nanoparticles in Bone Healing Applications.

Authors:  Alexandra-Cristina Burdușel; Oana Gherasim; Ecaterina Andronescu; Alexandru Mihai Grumezescu; Anton Ficai
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

Review 3.  Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review.

Authors:  Vanessa Marques Da Silva; Manon Benjdir; Pierrick Montagne; Jean-Claude Pairon; Sophie Lanone; Pascal Andujar
Journal:  Nanomaterials (Basel)       Date:  2022-07-13       Impact factor: 5.719

4.  Some Preliminary Results to Eradicate Leukemic Cells in Extracorporeal Circulation by Actuating Doxorubicin-Loaded Nanochains of Fe3O4 Nanoparticles.

Authors:  Xiawen Zheng; Xiaoli Mai; Siyuan Bao; Peng Wang; Yu Hong; Yuexia Han; Jianfei Sun; Fei Xiong
Journal:  Cells       Date:  2022-06-23       Impact factor: 7.666

5.  3D Printing of Diatomite Incorporated Composite Scaffolds for Skin Repair of Deep Burn Wounds.

Authors:  Jingge Ma; Jinfu Wu; Hongjian Zhang; Lin Du; Hui Zhuang; Zhaowenbin Zhang; Bing Ma; Jiang Chang; Chengtie Wu
Journal:  Int J Bioprint       Date:  2022-06-11

6.  Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer.

Authors:  Xiaoying Li; Yanzi Yu; Qi Chen; Jiabao Lin; Xueqiong Zhu; Xiaoting Liu; Lizhen He; Tianfeng Chen; Weiling He
Journal:  J Nanobiotechnology       Date:  2022-09-05       Impact factor: 9.429

7.  Engineered Mesoporous Silica-Based Core-Shell Nanoarchitectures for Synergistic Chemo-Photodynamic Therapies.

Authors:  Yue-Mei Gao; Shih-Han Chiu; Prabhakar Busa; Chen-Lun Liu; Ranjith Kumar Kankala; Chia-Hung Lee
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

8.  Nanoplatforms for Irinotecan Delivery Based on Mesoporous Silica Modified with a Natural Polysaccharide.

Authors:  Ana-Maria Brezoiu; Ana-Maria Prelipcean; Daniel Lincu; Mihaela Deaconu; Eugeniu Vasile; Rodica Tatia; Ana-Maria Seciu-Grama; Cristian Matei; Daniela Berger
Journal:  Materials (Basel)       Date:  2022-10-09       Impact factor: 3.748

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.